American biopharmaceutical firm AbbVie Inc has reportedly announced its decision to acquire Botox-maker Allergan Plc in a $63 billion deal. Apparently, this move would hand over the control of the profitable wrinkle remedy Botox to AbbVie,....

Galactosemia patients are in urgent need of treatment options and the company is committed to advancing AT-007 through clinical development Reports confirm that Applied Therapeutics Inc. has recently unveiled the initiation of a Phase 1/2 ....

Amazon Air recently announced that it plans to begin flights to Ted Stevens Anchorage International Airport. The airport published a post on twitter, confirming that the carrier will operate daily services to the Alaskan hub, utilizing its ....

Microsoft believes various versions of Slack do not offer sufficient controls to protect its intellectual property Microsoft has reportedly barred its more than 100,000 employees from using the free version of Slack. Apparently, Microsoft ....

·         JetBlue, in April, had given confirmation of its first service to Europe starting 2021 ·         Its new Airbus jet would serve cities ....

The new bikes would have a 338cc engine, by far the smallest engine model Harley has ever made, and will be sold in China by late 2020. American motorcycle manufacturer Harley-Davidson has reportedly announced to have inked a partners....

It will be the first time DT One will have mobile recharge originating from India through their network MobiKwik, an India based fintech platform, recently announced that it is partnering with DT One, a global network for mobile recharge a....

Phase 1/2a trial of RBM-007 was successfully conducted, yielding top-line results   Seven out of nine subjects showed a considerable improvement in Central Retinal Thickness Clinical stage pharmaceutical company RIBOMIC has recen....

Parker Aerospace, a business division of Parker Hannifin Corporation, one of the leaders in motion & control technologies, recently announced that its PowerGen division (Gas Turbine Fuel Systems) was awarded the fuel atomization nozzle ....

Editas Medicine Inc., a U.S.-based pharmaceutical company recently announced results from trial of two different CRISPR-Cas9 genome editing strategies, one targeting the beta-globin locus and the other targeting the erythroid enhancer, for ....